Literature DB >> 402432

Indirect immunofluorescent detection of antibodies against thermophilic actinomycetes in patients with hypersensitivity pneumonitis.

V P Kurup, J J Barboriak, J N Fink.   

Abstract

With slide culture preparations of Micropolyspora faeni, Thermoactinomyces candidus, and Thermoactinomyces vulgaris used as antigens, 59 sera from patients with hypersensitivity pneumonitis and 23 sera from normal controls were studied for the presence of specific antibodies by indirect immunofluorescence and immunodiffusion methods. Of the 82 sera, 31 showed precipitins to M. faeni, five to T. candidus, and four to T. vulgaris. A group of 19 sera positive to Aspergillus antigens showed questionable reactions to thermophilic actinomycetes. The 23 sera from normal individuals were negative for specific antibodies when tested by immunodiffusion. In indirect immunofluorescence studies, we found that IgG antibodies in high titers are present only in the precipitin-positive sera whereas other antibody classes either are negative or failed to show consistent differences in titers of the positive, questionable, and control groups. The titer of IgG antibodies varied from 0 to 1:20 in the normal control group, 0 to 1:40 to 1:640 in the precipitin-positive group.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402432

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Detection of IgG and IgE antibodies to Aspergillus fumigatus in human sera by immunogold assay.

Authors:  H C Gugnani; K E Reijula; V P Kurup; J N Fink
Journal:  Mycopathologia       Date:  1990-01       Impact factor: 2.574

2.  Farmers lung: a three year survey and comparison of ELISA and CIEP techniques in antibody detection.

Authors:  M Melinn; H McLaughlin
Journal:  Ir J Med Sci       Date:  1989-07       Impact factor: 1.568

3.  Immunofluorescent antibodies in patients with bird-fancier's lung.

Authors:  O E Eade; J R Hodges; W T Berrill; C Lang; R S Lloyd; R Wright
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.